These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 22467427)

  • 1. Key articles and guidelines in the management of pulmonary arterial hypertension: 2011 update.
    Johnson SG; Kayser SR; Attridge RL; Duvall L; Kiser TH; Moote R; Reed BN; Rodgers JE; Erstad B
    Pharmacotherapy; 2012 Jun; 32(6):e134-69. PubMed ID: 22467427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-impact articles related to the management of heart failure: 2008 update.
    Jackevicius CA; Page RL; Chow S; Dunn SP; Lee CR; Ng TM; Rodgers JE; Vardeny O; Wiggins BS; Munger MA
    Pharmacotherapy; 2009 Jan; 29(1):82-120. PubMed ID: 19113799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-impact articles related to the pharmacotherapeutic management of systolic heart failure.
    Ng TM; Carter O; Guillory GS; Howard PA; Lee CR; Rodgers JE; Uber PA; Wiggins BS; Munger MA; Patterson JH
    Pharmacotherapy; 2004 Nov; 24(11):1594-633. PubMed ID: 15537564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current treatment strategies for pulmonary arterial hypertension.
    Lee SH; Rubin LJ
    J Intern Med; 2005 Sep; 258(3):199-215. PubMed ID: 16115293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of dyspnea in advanced pulmonary arterial hypertension.
    Sajkov D; Petrovsky N; Palange P
    Curr Opin Support Palliat Care; 2010 Jun; 4(2):76-84. PubMed ID: 20407377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current therapeutics and practical management strategies for pulmonary arterial hypertension.
    Agarwal R; Gomberg-Maitland M
    Am Heart J; 2011 Aug; 162(2):201-13. PubMed ID: 21835279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of combination therapy in the treatment of pulmonary arterial hypertension.
    Abraham T; Wu G; Vastey F; Rapp J; Saad N; Balmir E
    Pharmacotherapy; 2010 Apr; 30(4):390-404. PubMed ID: 20334459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2009 ESC/ERS pulmonary hypertension guidelines and connective tissue disease.
    Nakanishi N; ;
    Allergol Int; 2011 Dec; 60(4):419-24. PubMed ID: 22015568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Update: Current clinical developments in pulmonary hypertension].
    Dumitrescu D; Ghofrani HA; Grimminger F; Hoeper MM; Rosenkranz S
    Dtsch Med Wochenschr; 2009 Aug; 134 Suppl 5():S160-3. PubMed ID: 19718605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension.
    Montani D; Chaumais MC; Savale L; Natali D; Price LC; Jaïs X; Humbert M; Simonneau G; Sitbon O
    Adv Ther; 2009 Sep; 26(9):813-25. PubMed ID: 19768639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapeutic management of pulmonary arterial hypertension.
    Anderson JR; Nawarskas JJ
    Cardiol Rev; 2010; 18(3):148-62. PubMed ID: 20395700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pulmonary arterial hypertension].
    Jaïs X; Sitbon O; Savale L; Montani D; Humbert M; Simonneau G
    Rev Prat; 2008 Nov; 58(18):1997-2010. PubMed ID: 19143271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging drugs for pulmonary hypertension.
    Girgis RE
    Expert Opin Emerg Drugs; 2010 Mar; 15(1):71-85. PubMed ID: 20095920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compelling evidence of long-term outcomes in pulmonary arterial hypertension? A clinical perspective.
    Gomberg-Maitland M; Dufton C; Oudiz RJ; Benza RL
    J Am Coll Cardiol; 2011 Mar; 57(9):1053-61. PubMed ID: 21349396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary hypertension due to left heart disease: updated Recommendations of the Cologne Consensus Conference 2011.
    Rosenkranz S; Bonderman D; Buerke M; Felgendreher R; ten Freyhaus H; Grünig E; de Haan F; Hammerstingl C; Harreuter A; Hohenforst-Schmidt W; Kindermann I; Kindermann M; Kleber FX; Kuckeland M; Kuebler WM; Mertens D; Mitrovic V; Opitz C; Schmeisser A; Schulz U; Speich R; Zeh W; Weil J
    Int J Cardiol; 2011 Dec; 154 Suppl 1():S34-44. PubMed ID: 22221972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New and future therapies in pulmonary arterial hypertension.
    Bull TM
    Semin Respir Crit Care Med; 2005 Aug; 26(4):429-36. PubMed ID: 16121320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dana Point: what is new in the treatment of pulmonary hypertension?].
    Hoeper MM; Ghofrani HA; Grimminger F; Rosenkranz S
    Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S191-5. PubMed ID: 18814094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel approaches to the pharmacotherapy of pulmonary arterial hypertension.
    Olsson KM; Hoeper MM
    Drug Discov Today; 2009 Mar; 14(5-6):284-90. PubMed ID: 19121410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension.
    Galiè N; Seeger W; Naeije R; Simonneau G; Rubin LJ
    J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):81S-88S. PubMed ID: 15194183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.